We are live on ! Find out more
VP

venBio Partners Portfolio holdings

AUM $281M
1-Year Est. Return 261.03%
This Fund
S&P 500
This Quarter Est. Return
+16.8%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$162M
AUM Growth
+$61.5M
Cap. Flow
+$49.4M
Cap. Flow %
30.43%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

1
VYNE icon
VYNE Therapeutics
VYNE
+$49.4M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 51.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYNE icon
1
VYNE Therapeutics
VYNE
$25.9M
$54.9M 33.85%
+20,299
New +$49.4M
VRNA
2
DELISTED
Verona Pharma
VRNA
$17.5M 10.79%
875,000
– –
NBRV
3
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$10.7M 6.58%
8,492
– –

Similar funds

OCWP
Owl Creek Wealth Partners Denver, Colorado $281M AUM
FFP
Freedom Financial Partners Oakdale, Minnesota $281M AUM 16.89% 1-Year Est. Return
BDA
Borer Denton & Associates Blue Bell, Pennsylvania $280M AUM 7.09% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
ACC
Acorn Creek Capital Fort Collins, Colorado $280M AUM 19.97% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return